Maple-Brown Abbott’s Sempra SRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $94.3M | Buy |
1,320,706
+609,386
| +86% | +$47.5M | 6.43% | 7 |
|
|
2024
Q4 | $62.4M | Sell |
711,320
-388,010
| -35% | -$34M | 7.61% | 8 |
|
|
2024
Q3 | $91.9M | Sell |
1,099,330
-136,700
| -11% | -$10.9M | 9.12% | 6 |
|
|
2024
Q2 | $94M | Sell |
1,236,030
-86,710
| -7% | -$6.41M | 9.91% | 3 |
|
|
2024
Q1 | $95M | Buy |
1,322,740
+179,080
| +16% | +$12.8M | 9.72% | 5 |
|
|
2023
Q4 | $85.5M | Buy |
1,143,660
+41,970
| +4% | +$3M | 8.7% | 6 |
|
|
2023
Q3 | $74.9M | Sell |
1,101,690
-28,730
| -3% | -$2.07M | 8.6% | 6 |
|
|
2023
Q2 | $82.3M | Buy |
1,130,420
+5,884
| +0.5% | +$442K | 9.14% | 5 |
|
|
2023
Q1 | $85M | Buy |
1,124,536
+105,100
| +10% | +$8.06M | 9.67% | 6 |
|
|
2022
Q4 | $78.8M | Sell |
1,019,436
-26,440
| -3% | -$2.05M | 9.21% | 6 |
|
|
2022
Q3 | $78.4M | Sell |
1,045,876
-134,580
| -11% | -$10.9M | 10.1% | 4 |
|
|
2022
Q2 | $88.7M | Sell |
1,180,456
-392,974
| -25% | -$31.6M | 8.82% | 6 |
|
|
2022
Q1 | $132M | Sell |
1,573,430
-935,894
| -37% | -$67.3M | 9.24% | 5 |
|
|
2021
Q4 | $166M | Sell |
2,509,324
-532,564
| -18% | -$33.7M | 11.07% | 3 |
|
|
2021
Q3 | $192M | Buy |
3,041,888
+67,060
| +2% | +$4.43M | 10.69% | 3 |
|
|
2021
Q2 | $197M | Buy |
2,974,828
+179,740
| +6% | +$12.3M | 10.63% | 3 |
|
|
2021
Q1 | $185M | Buy |
2,795,088
+734,680
| +36% | +$45.7M | 10.39% | 2 |
|
|
2020
Q4 | $131M | Buy |
2,060,408
+152,540
| +8% | +$9.81M | 8.48% | 6 |
|
|
2020
Q3 | $113M | Sell |
1,907,868
-78,348
| -4% | -$4.82M | 8.87% | 3 |
|
|
2020
Q2 | $116M | Buy |
1,986,216
+364,800
| +22% | +$22.4M | 9.09% | 5 |
|
|
2020
Q1 | $91.6M | Buy |
1,621,416
+171,944
| +12% | +$12.2M | 8.2% | 5 |
|
|
2019
Q4 | $110M | Sell |
1,449,472
-88,400
| -6% | -$6.49M | 8.2% | 5 |
|
|
2019
Q3 | $114M | Buy |
1,537,872
+96,040
| +7% | +$6.72M | 8.97% | 5 |
|
|
2019
Q2 | $99.1M | Buy |
1,441,832
+242,120
| +20% | +$15.9M | 8.38% | 5 |
|
|
2019
Q1 | $76.8M | Sell |
1,199,712
-8,120
| -0.7% | -$478K | 6.42% | 8 |
|
|
2018
Q4 | $65.3M | Sell |
1,207,832
-80,156
| -6% | -$4.57M | 5.86% | 10 |
|
|
2018
Q3 | $73.3M | Buy |
1,287,988
+244,076
| +23% | +$14.1M | 5.84% | 9 |
|
|
2018
Q2 | $60.6M | Sell |
1,043,912
-23,800
| -2% | -$1.3M | 4.73% | 11 |
|
|
2018
Q1 | $59.4M | Buy |
1,067,712
+189,400
| +22% | +$10.2M | 5.03% | 12 |
|
|
2017
Q4 | $47M | Sell |
878,312
-460,018
| -34% | -$26.7M | 3.94% | 13 |
|
|
2017
Q3 | $76.4M | Buy |
1,338,330
+74,800
| +6% | +$4.33M | 7.59% | 4 |
|
|
2017
Q2 | $71.2M | Buy |
1,263,530
+184,200
| +17% | +$10.4M | 7.34% | 5 |
|
|
2017
Q1 | $59.6M | Buy |
1,079,330
+45,400
| +4% | +$2.41M | 7.29% | 5 |
|
|
2016
Q4 | $52M | Buy |
1,033,930
+474,808
| +85% | +$24.2M | 7.31% | 6 |
|
|
2016
Q3 | $30M | Buy |
559,122
+412,722
| +282% | +$22.5M | 6.59% | 8 |
|
|
2016
Q2 | $8.35M | Buy |
146,400
+13,800
| +10% | +$731K | 2.58% | 16 |
|
|
2016
Q1 | $6.9M | Buy |
+132,600
| New | +$6.39M | 2.29% | 16 |
|
Other funds holding SRE
Maple-Brown Abbott's SRE Position: Q1 2025 in Review
Maple-Brown Abbott increased its Sempra (SRE) stake by 86% in Q1 2025, buying an estimated $47.5M and bringing the position to 1,320,706 shares worth $94.3M. The position accounts for 6.43% of the portfolio, ranked #7.
Maple-Brown Abbott first reported a position in SRE in Q1 2016 and has held it in 37 quarters since. The position peaked at $197M in Q2 2021. 1,144 funds tracked by Wall St. Rank hold SRE as of Q1 2025.
- Maple-Brown Abbott held 1,320,706 shares of Sempra worth $94.3M as of Q1 2025.
- Maple-Brown Abbott bought 609,386 Sempra shares in Q1 2025, an estimated $47.5M.
- Sempra made up 6.43% of Maple-Brown Abbott's portfolio in Q1 2025, its #7 holding.
- Maple-Brown Abbott first reported a position in Sempra in Q1 2016 and has held it in 37 quarters since.
- Maple-Brown Abbott's Sempra position peaked at $197M in Q2 2021.
- 1,144 funds tracked by Wall St. Rank held Sempra as of Q1 2025.
Based on Maple-Brown Abbott's 13F filing for Q1 2025, filed 13 May 2025.